REXN - Rexahn Pharmaceuticals EPS beats by $0.34 August, 07 2019 06:47 AM Rexahn Pharmaceuticals Rexahn Pharmaceuticals (NYSEMKT:REXN): Q2 GAAP EPS of -$0.61 beats by $0.34.Cash and equivalents of $16.3M.Press ReleaseMore news on: Rexahn Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,